CHUV, Médecine du Personnel et d'Entreprise, Lausanne University Hospital, Lausanne, Switzerland
CHUV, Médecine du Personnel et d'Entreprise, Lausanne University Hospital, Lausanne, Switzerland.
BMJ Case Rep. 2024 Oct 26;17(10):e260966. doi: 10.1136/bcr-2024-260966.
A man in his mid-20s presented to the occupational health service following an ocular projection with a concentrated solution of lymphocytic choriomeningitis virus (LCMV clone-13). Subsequently, a regular clinical and biological follow-up was initiated. 7 days after exposure, the patient developed influenza-like symptoms. During the acute phase, specific RT-PCR testing of blood plasma was negative for LCMV. Symptomatic treatment was administered, and the symptoms resolved after a few days. The patient remained asymptomatic in the following weeks. Serological follow-up detected a seroconversion 6 weeks after exposure, indicating a recent infection. The occupational health service's protocol, comprising clinical monitoring and serological surveillance, facilitated the detection of seroconversion. This case underscores ocular mucosal exposure as a route of occupational LCMV transmission, which is often not considered. It served as an opportunity to review and enhance prevention measures and laboratory protocols within the biosafety level P2 facility.
一名 20 多岁的男性在眼部接触浓缩淋巴细胞脉络丛脑膜炎病毒(LCMV 克隆-13)溶液后,前往职业健康服务中心就诊。随后,开始进行常规临床和生物学随访。暴露后 7 天,患者出现流感样症状。在急性期,对血浆进行的特定 RT-PCR 检测结果 LCMV 呈阴性。给予对症治疗,几天后症状缓解。在接下来的几周里,患者无症状。血清学随访在暴露后 6 周时检测到血清转换,表明近期感染。职业健康服务中心的方案包括临床监测和血清学监测,有助于检测到血清转换。该病例强调了眼部黏膜暴露是职业性 LCMV 传播的一种途径,而这种途径通常不被认为是感染源。这为在生物安全水平 P2 设施中审查和加强预防措施和实验室方案提供了机会。